BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35089603)

  • 1. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
    Szuber N; Elliott M; Tefferi A
    Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
    Szuber N; Orazi A; Tefferi A
    Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Management of Chronic Neutrophilic Leukemia.
    Szuber N; Tefferi A
    Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neutrophilic leukemia: new science and new diagnostic criteria.
    Szuber N; Tefferi A
    Blood Cancer J; 2018 Feb; 8(2):19. PubMed ID: 29440636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review.
    Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y
    BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetics of chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
    Elliott MA; Tefferi A
    Curr Opin Hematol; 2014 Mar; 21(2):148-54. PubMed ID: 24335708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic neutrophilic leukemia: novel mutations and their impact on clinical practice.
    Tefferi A; Elliott M; Pardanani A
    Curr Opin Hematol; 2015 Mar; 22(2):171-6. PubMed ID: 25575036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution in a chronic neutrophilic leukemia patient.
    Zhang QG; Wang J; Gong WY; Jing QC
    Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current strategies in the diagnosis and management of chronic neutrophilic leukemia.
    Otgonbat A; Zhao M
    Chin Med J (Engl); 2014; 127(24):4258-62. PubMed ID: 25533830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Tyner JW; Gotlib J
    Curr Hematol Malig Rep; 2017 Oct; 12(5):432-441. PubMed ID: 28983816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
    Maxson JE; Gotlib J; Pollyea DA; Fleischman AG; Agarwal A; Eide CA; Bottomly D; Wilmot B; McWeeney SK; Tognon CE; Pond JB; Collins RH; Goueli B; Oh ST; Deininger MW; Chang BH; Loriaux MM; Druker BJ; Tyner JW
    N Engl J Med; 2013 May; 368(19):1781-90. PubMed ID: 23656643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia.
    Adam FC; Szybinski J; Halter JP; Cantoni N; Wenzel F; Leonards K; Brkic S; Passweg JR; Touw I; Maxson JE; Meyer SC
    Curr Oncol; 2022 Feb; 29(2):805-815. PubMed ID: 35200567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
    Gotlib J; Maxson JE; George TI; Tyner JW
    Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.